CDC Expert Commentary

• The Impact of COVID-19 on Antimicrobial Resistance in the US   Arjun Srinivasan, MD, deputy director for program improvement in the division of healthcare quality promotion at the CDC, discusses the impact of COVID-19 on antimicrobial resistance.
  CDC Expert Commentary, September 27, 2022
• Case: Woman Presents to ED With Headache and Hypertension A 25-year-old woman presents with severe, throbbing headache and episodes of blurred vision with BP rising over the next few hours to a hypertensive emergency. Test your diagnostic skills.
  CDC Expert Commentary, September 23, 2022
• CDC Revamps Flu Vaccine Recommendation for Older Adults Higher-dose and adjuvanted flu vaccines may be more effective in older adults whose immune systems are not as strong.
  CDC Expert Commentary, September 14, 2022
• Monkeypox Vaccines: Q&A With the CDC's Agam Rao, MD Two vaccines are available for monkeypox. A CDC vaccine expert answers questions about their effectiveness and dosing.
  CDC Expert Commentary, September 02, 2022
• Treating Monkeypox: Q&A with the CDC's John T. Brooks, MD Sexually active men who have sex with men are most at risk for infection with the virus, which can cause excruciatingly painful lesions and even scarring.
  CDC Expert Commentary, August 22, 2022
• What Does It Mean Now That Polio Is Back? One case of paralytic polio could mean many poliovirus infections in a community, and unvaccinated people are most at risk.
  CDC Expert Commentary, August 16, 2022
• Back-to-School Vaccinations Making sure that children are up-to-date on all their vaccinations, including COVID-19, is an essential part of the preparation for the upcoming school year.
  CDC Expert Commentary, July 28, 2022
• 5 Things to Know About the New 4-Month TB Treatment Regimen The CDC recommends this treatment option only for certain patient groups.
  CDC Expert Commentary, July 08, 2022
• 5 Things to Know About Ehrlichiosis and Anaplasmosis Ehrlichiosis and anaplasmosis are emerging but underrecognized tickborne diseases in the United States
  CDC Expert Commentary, June 21, 2022
• H5N1 Avian Influenza: Q&A With the CDC's Tim Uyeki, MD Dr Tim Uyeki, Chief Medical Officer of the Influenza Division at the Centers for Disease Control and Prevention, answers questions about H5N1 avian influenza, commonly called "bird flu."
  CDC Expert Commentary, June 08, 2022
• Update on Rabies, TBE, and Cholera Vaccines Before Travel Healthcare providers should be aware of important updates to vaccine recommendations that could affect patients preparing to travel internationally this summer.
  CDC Expert Commentary, May 27, 2022
• New HIV PrEP Guidelines This update gives healthcare providers the latest guidance on prescribing HIV pre-exposure prophylaxis (PrEP) -- a powerful tool for HIV prevention -- to their patients.
  CDC Expert Commentary, May 11, 2022
• COVID-19 Vaccine Effectiveness CDC answers questions about how effective vaccines are against preventing serious illness with newer COVID variants.
  CDC Expert Commentary, May 03, 2022
• Shingles Vaccination for Immunocompromised Adults In January 2022, CDC updated recommendations for shingles vaccination to include people 19 years and older who are or will be immunocompromised.
  CDC Expert Commentary, March 22, 2022
• Invasive Mold in Patients With COVID-19 COVID-19 is likely to increase the risk for pulmonary aspergillosis and mucormycosis, life-threatening infections caused by environmental molds.
  CDC Expert Commentary, March 03, 2022
• 5 Things to Know About New Pneumococcal Vaccine Guidance Adult pneumococcal vaccine recommendations have been considered some of the most complicated vaccine recommendations to appropriately implement. The good news: Implementation just got simpler.
  CDC Expert Commentary, February 17, 2022
• Testing and Treatment for COVID-19 and Influenza Given the similarities between symptoms of influenza and COVID-19, distinguishing between the two diseases when both are spreading in the community is challenging.
  CDC Expert Commentary, January 19, 2022
• Studying Abroad During COVID-19: 5 Things to Know CDC is providing five important reminders for healthcare providers to share with their patients, be they students or faculty, who plan to study abroad while the pandemic continues.
  CDC Expert Commentary, December 09, 2021
• ACTIV COVID-19 Clinical Trials ACTIV trials were designed for a rigorous assessment of safety and efficacy in flexible, multi-stage, multi-arm, randomized controlled designs.
  CDC Expert Commentary, November 12, 2021
• Antibiotic Use During COVID-19 Stewardship programs are critical for optimizing patient safety, and there are opportunities to optimize antibiotic use during the COVID-19 pandemic.
  CDC Expert Commentary, October 19, 2021